Infants and children aged <2 years are strongly recommended to receive MenB vaccine
All infants and children aged <2 years are strongly recommended to receive MenB vaccine. Infants and children aged <10 year can receive Bexsero as it is the only MenB vaccine registered for use in this age group and available in Australia.
The number of doses required depends on the age of the child when they start the vaccine course.
Table. Recommendations for immunisation of infants and children aged <2 years using meningococcal B vaccine
Medical conditions are specified in List. Specified medical conditions associated with increased risk of invasive meningococcal disease.
| Age at start of vaccine course | MenB vaccine brand | Dose requirements for healthy people (without any medical conditions associated with increased risk of invasive meningococcal disease) |
|---|---|---|
|
6 weeks to 11 months |
Bexsero |
3 doses (8 weeks between 1st and 2nd doses; 3rd dose at 12 months of age or 8 weeks after 2nd dose, whichever is later) |
|
12–23 months |
Bexsero |
2 doses (8 weeks between doses) |
Related diseases
Page history
Last updated
Last reviewed